Variables | EphA3 | |||
---|---|---|---|---|
n n = 202 | Low n = 111 (n, %) | High n = 91 (n, %) | p value | |
Age | ||||
< 65 | 97 | 60 (61.9) | 37 (38.1) | 0.067 |
≥ 65 | 105 | 51 (48.6) | 54 (51.4) | |
Gender | ||||
Female | 48 | 33 (68.8) | 15 (31.3) | 0.031 |
Male | 154 | 78 (50.6) | 76 (49.4) | |
Main location | ||||
Middle or Lower | 160 | 93 (58.1) | 67 (41.9) | 0.084 |
Upper | 42 | 18 (42.9) | 24 (57.1) | |
WHO pathological type | ||||
Differentiated | 99 | 39 (39.4) | 60 (60.6) | <0.001 |
Undifferentiated | 103 | 72 (69.9) | 31 (30.1) | |
Depth of invasion | ||||
T1 | 87 | 59 (67.8) | 28 (32.2) | 0.002 |
T2/3/4 | 115 | 52 (45.2) | 63 (54.8) | |
Lymph node metastasis | ||||
Negative | 113 | 74 (65.5) | 39 (34.5) | 0.001 |
Positive | 89 | 37 (41.6) | 52 (58.4) | |
Stage | ||||
I | 106 | 72 (67.9) | 34 (32.1) | <0.001 |
II/III | 96 | 39 (40.4) | 57 (59.4) | |
Distant recurrence | ||||
Negative | 152 | 91 (59.9) | 61 (40.1) | 0.021 |
Positive | 50 | 20 (40) | 30 (60) | |
Liver recurrence | ||||
Negative | 194 | 110 (56.7) | 84 (43.3) | 0.024 |
Positive | 8 | 1 (12.5) | 7 (87.5) | |
Peritoneal recurrence | ||||
Negative | 182 | 99 (54.4) | 83 (45.6) | 0.814 |
Positive | 20 | 12 (60) | 8 (40) | |
HER2 | ||||
Negative | 186 | 107 (57.5) | 79 (42.5) | 0.017 |
Positive | 16 | 4 (25) | 12 (75) |